Previous 10 | Next 10 |
2023-08-08 07:47:53 ET Harvard Bioscience press release ( NASDAQ: HBIO ): Q2 Non-GAAP EPS of $0.04 misses by $0.02 . Revenue of $28.2M (-3.4% Y/Y) misses by $1.3M . For further details see: Harvard Bioscience Non-GAAP EPS of $0.04 misses by $0.02, revenue...
Q2 Revenues of $28.8 million Q2 GAAP operating income $0.8 million, adjusted operating income $3.6 million Strong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO)...
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the com...
HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Pa...
2023-06-26 17:20:36 ET Gainers: Terns Pharmaceuticals ( NASDAQ: TERN ) +7% . Savara ( SVRA ) +5% . Nkarta ( NKTX ) +5% . COMPASS Pathways ( CMPS ) +3% . Matterport ( MTTR ) +2% . Losers: Adicet ( ACET ...
2023-06-22 08:06:17 ET Life science applications company Harvard Bioscience ( NASDAQ: HBIO ) said on Thursday that it is set to join the Russell 2000 and Russell 3000 indexes from the conclusion of the 2023 Russell indexes annual reconstitution. The addition is effective ...
HOLLISTON, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000 ® and Russell 3000 Indexes, according to preliminary membership information posted to the FTSE Russell website...
2023-06-20 17:06:52 ET Summary Today, we take our first look at medical device concern Harvard Bioscience, Inc. The shares have doubled over the past few months on better-than-expected results and improving cash flow. Can the rally continue? An investment analysis follows in t...
2023-06-20 08:10:08 ET Life science applications company Harvard Bioscience ( NASDAQ: HBIO ) said on Tuesday that Jennifer Cote has been appointed CFO and treasurer, effective June 19. Cote has been the interim CFO and treasurer since January. Source: Press Release ...
HOLLISTON, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer, effective June 19, 2023. Cote joined the Company as Vice Presid...
News, Short Squeeze, Breakout and More Instantly...
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriot...
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22 ...